Top Markets
Coin of the day
Glenmark Life Sciences Limited Glenmark Life Sciences Limited

Glenmark Life Sciences Limited

GLS
Clasificación en acciones #7695
Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011,... Glenmark Life Sciences Limited, an Indian entity established in Mumbai in 2011, specializes in the creation, manufacturing, and distribution of high-value active pharmaceutical ingredients (APIs). These APIs are utilized across a wide array of chronic therapeutic areas. The company's diverse portfolio includes compounds for managing cardiovascular diseases (e.g., Olmesartan, Rosuvastatin, Amiodarone), central nervous system conditions (such as Oxcarbazepine, Topiramate, Lacosamide), and diabetes (including Glimepiride, Teneligliptin, Linagliptin). Additionally, they produce APIs for pain management (Etoricoxib, Lornoxicam), gastro-intestinal disorders, anti-infective treatments, respiratory ailments, and anti-emetic applications, featuring products like Atovaquone, Fluconazole, and Esomeprazole Magnesium. Beyond API production, Glenmark Life Sciences offers contract development and manufacturing (CDMO) solutions to numerous multinational and specialty pharmaceutical firms. Operating as a subsidiary of Glenmark Pharmaceuticals Limited, the company exports its products worldwide, reaching markets in Europe, North America, Latin America, and Japan.
Precio por acción
$12.18
Última sincronización: 2025-02-17
Capitalización bursátil
$1.49B
Cambio (1 día)
4.21%
Cambio (1 año)
0.00%
País
IN
Comercio Glenmark Life Sciences Limited (GLS)

Categoría

Historial de desdoblamientos de acciones de Glenmark Life Sciences Limited (GLS)
La acción Glenmark Life Sciences Limited (símbolo: GLS) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 28, 2026.
Una acción GLS comprada antes de Aug 28, 2026 equivaldría hoy a 0 acciones GLS.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
0 -
DE
0 -
DE
0 -
JP
0 -
CH
5 x119
IN